It would be devastating to lose your eyesight to macular degeneration. Age-related macular degeneration (AMD) is a progressive eye disease that affects those over the age of 50. There is ...

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.

Annexon, Inc. reports complete enrollment in the ARCHER II trial for vonaprument, targeting dry AMD with topline data due 2026. Annexon, Inc. announced the successful completion of enrollment for its ...

Ahead of her 91st birthday on Tuesday, Dame Judi Dench has opened up about her worsening eyesight. The beloved actress was first diagnosed with age-related macular degeneration (AMD) in 2012, and ...

Around a third of people over the age of 80 suffer from age-related macular degeneration (AMD), with an estimated 20 million Americans aged 40 and older currently living with AMD. Most cases are the ...

At least 20 million Americans ages 40 and older have age-related macular degeneration, and the threat posed by the vision-robbing condition will only grow larger as the population ages. Despite the ...

The evidence evaluating the effect of cataract surgery on the chances people with dry age-related macular degeneration (AMD) will convert to the more severe wet form of the condition has been uneven ...

Potential for Vonaprument to Be the First Treatment Approved in Europe and the U.S. for Dry AMD with Geographic Atrophy Based on Protection of Visual Acuity and Structural Measures BRISBANE, Calif., ...

View post: Running Legend and Founder of the Run-Walk-Run Method Dies at 80. Here's How 'Jeffing' Helps Runners of All Experience Levels Coffee-AMD-2024 Instant coffee consumption may increase risk of ...

PARIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology ...